Misonix Story

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:3em;'>MSO</div>
MSON -- USA Stock  

USD 17.13  0.67  3.76%

MISONIX Market Capitalization is quite stable at the moment as compared to the past year. The company's current value of Market Capitalization is estimated at 292.33 Million. Tangible Asset Value is expected to rise to about 91.1 M this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (14 M). In this article, we will outline MISONIX as a potential position in addition to your existing holdings. We will inspect why it could be a game-changer for MISONIX institutional investors.
Published over two weeks ago
View all stories for Misonix | View All Stories
Are MISONIX (NASDAQ:MSON) institutional investors starting to hold back?
About 22.0% of MISONIX outstanding shares are owned by corporate insiders. Insiders ownership of MISONIX refers to the amount of MISONIX equity owned by MISONIX officers, directors, relatives of the leadership team, or anyone who has access to private information before it's made available to the public. Check out our latest analysis of MISONIX, including its current ownership diagnostics.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Misonix. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for Misonix

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Misonix's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Misonix in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Misonix. Your research has to be compared to or analyzed against Misonix's peers to derive any actionable benefits. When done correctly, Misonix's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Misonix.

How important is Misonix's Liquidity

Misonix financial leverage refers to using borrowed capital as a funding source to finance Misonix ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Misonix financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Misonix's total debt and its cash.

How Misonix utilizes its cash?

To perform a cash flow analysis of Misonix, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Misonix is receiving and how much cash it distributes out in a given period. The Misonix cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Misonix Net Cash Flow from Operations is quite stable at the moment as compared to the past year. The company's current value of Net Cash Flow from Operations is estimated at (24.65 Million)

Acquisition by Charles Miner of 15000 shares of MISONIX subject to Rule 16b-3

Legal trades by Misonix insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
MISONIX insider trading alert for grant of stock option by Charles Miner, the corporate stakeholder, on 12th of February 2021. This event was filed by Misonix Inc with SEC on 2018-11-16. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking it down a bit more

The latest price rise of MISONIX may encourage institutional investors to take a closer look at the firm as it is trading at a share price of 18.75 on very low momentum in trading volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in March. The stock standard deviation of daily returns for 30 days investing horizon is currently 5.1. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the MISONIX partners.

Margin Breakdown

EBITDA Margin(0.29)
Gross Margin0.79
Profit Margin(0.26)

Our perspective of the latest MISONIX rise

Market risk adjusted performance is down to 0.56. It may entail a possible volatility slide. MISONIX currently demonstrates below-verage downside deviation. It has Information Ratio of 0.15 and Jensen Alpha of 0.71. However, we do advice investors to further question MISONIX expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk.

The Current Takeaway on MISONIX Investment

Whereas some other firms under the medical devices industry are still a bit expensive, MISONIX may offer a potential longer-term growth to institutional investors. To summarize, as of the 6th of February 2021, we believe that MISONIX is currently undervalued with low probability of distress in the next two years. Our current 30 days buy vs. sell advice on the company is Strong Buy.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Achuva Shats do not own shares of Misonix. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com